BDBM716526 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-propyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 48

SMILES CCCc1ccc(OC(F)(F)F)cc1C1=NNC(C(=O)N[C@@H]2C[C@@H](Cn3ccnn3)N(C#N)C2)O1

InChI Key InChIKey=WJMZTYQIGLSORN-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 716526   

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM716526(N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cya...)
Affinity DataIC50: 5nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well polypropylen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
US Patent